Also known as: LY3437943, Triple Agonist
Retatrutide is a newer triple agonist. That means it turns on three receptors (docking spots on cells) at once: GLP-1, GIP and glucagon. It is now being tested in Phase III human trials. So far, it has shown more weight loss than any other peptide. In Phase II trials, people lost 20–25%+ of their body weight (vs ~15% for Tirzepatide). The glucagon part makes the body burn more energy. This adds to the drop in appetite. This is the prefilled pen kit. Prefilled pen, needle tips and alcohol wipes included.
Size
Bundle & Save
$130
10mg
Free Xpresspost shipping on orders over $300
The strength shown is the total amount in the pen, not a single dose. Check the instructions that come with the pen for the concentration, the dose per click and how long the pen lasts once you start using it. Mixing steps and syringe-unit examples for vials do not apply to prefilled pens.
The pen comes prefilled, so do not mix it with water. Follow the instructions that come with the pen for temperature, keeping it out of light and how long it lasts once in use. Storage and mixing steps for dry-powder vials do not apply to this kit. Contact us if these details are missing.
Retatrutide is also sold as a vial. The vial page has the full research notes. See Retatrutide vials.
Research pen kit. It is not an approved branded medicine or injection device. Investigational drug (Phase III). Not yet approved. Available as research chemical.
Zenova Rewards
One spin per account. Six equal-chance slots, including two BOGO slots, plus 5% back in points on paid orders.
Zenova Peptides
For laboratory research purposes only. Not for human use. Not medical advice.
No reviews for Retatrutide Pen Kit yet. If you have used it, yours would be the first.